Without surgery 88% of women reported results
High risk defined as individuals with a higher risk of complications, comorbid conditions (e.g., cognitive deficits, kidney disease, joint disease, osteoporosis, fracture, and/or cardiovascular disease), and those requiring assisted care, which can complicate treatment prescriptions
Sermorelin: This is typically used instead of Tesamorelin, not in addition to it, as their mechanisms are very similar
For those dealing with obesity or excess weight, especially when accompanied by health complications, semaglutides ability to curb appetite and assist with weight loss presents a promising option
Dosing ranges from 0.25 mg to 2.4 mg weekly for semaglutide, 0.75 mg to 4.5 mg weekly for dulaglutide, and 0.6 mg to 3 mg daily for liraglutide, with your healthcare provider determining the optimal dose based on glycemic control, tolerability, renal function, and cardiovascular risk factors